By contrast, using a similar experimental setup, depleting NK cells and ILCs (using Thy1 antibody) abolished any protective tumor effects rendered by PD-1 blocking in these murine recipients (Fig. 7 D and E and SI Appendix, Fig. S7B). The gene discussed is THY1; the disease is neoplasm.